Obamacare, Medicare and Biosimilar Drugs and the Price You Pay.
Medicare Part D beneficiaries will pay more for biosimilar drugs (are similar — but not identical — to the brand-name
Read MoreMedicare Part D beneficiaries will pay more for biosimilar drugs (are similar — but not identical — to the brand-name
Read More(By Michelle Andrews for Kaiser Health News) Denise Johnson works two jobs, but neither of them offers health insurance to
Read More(By Phil Galewitz for Kaiser Health News) If UnitedHealthcare follows through on its threat to quit the health insurance marketplaces
Read MoreMost Americans think Medicare will pay for long-term supports and services (LTSS); but it does not. In a recent blog
Read MoreEveryone agrees the Medicare program cannot sustain itself beyond the year 2030 without some sort of intervention on keeping costs
Read MoreUnitedHealth Group announced that they will be exiting the Michigan’s exchange at the end of this year in effort to
Read MoreIn a legal brief filed by the Obama administration at the Supreme Court in the Little Sisters of Poor case,
Read More(By Todd Bookman, WHYY for Kaiser Health News) Erika Stallings’ mom was diagnosed with breast cancer at the age of
Read MoreIn the journal Science this week, P’ng Loke and Ken Caldwell, two researchers at New York University published their findings
Read More(By Michelle Andrews for Kaiser Health News) If you have cancer, chances are your outpatient chemotherapy treatment costs are higher
Read More